Pravin Mundada

Pravin Mundada

Auto-generated profile, based on publicly available information

Pravin Mundada

Division of Radiology, Department of Imaging and Medical Informatics, Geneva University Hospitals, University of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211, Geneva 14, Switzerland

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in European Journal of Radiology
Verified
Journal Article
Closed access
PMPravin Mundada
Pravin Mundada
MBMinerva Becker
Minerva Becker
VLVincent Lenoir
Vincent Lenoir
SSSalvatore Stefanelli
Salvatore Stefanelli
ARAnne-Laure Rougemont
Anne-Laure Rougemont
SBSana Boudabbous
Sana Boudabbous

29 December 2015 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
PMPravin Mundada
Pravin Mundada
BPBela Satish Purohit
Bela Satish Purohit
TKTahira Sultana Kumar
Tahira Sultana Kumar
TTTiong Yong Tan
Tiong Yong Tan
Dir Journal Diagnostic and Interventional Radiology

15 February 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
AAA. Ailianou
A. Ailianou
PMP. Mundada
P. Mundada
TPThomas De Perrot
Thomas De Perrot
MPM. Pusztaszieri
M. Pusztaszieri
PPPierre-Alexandre POLETTI
Pierre-Alexandre POLETTI
MBMinerva Becker
Minerva Becker
BACKGROUND AND PURPOSE: Although diffusion-weighted imaging combined with morphologic MRI (DWIMRI) is used to detect posttreatment recurrent and second primary head and neck squamous cell carcinoma, the diagnostic criteria used so far have not been clarified. We hypothesized that precise MRI criteria based on signal intensity patterns on T2 and contrast-enhanced T1 complement DWI and therefore improve the diagnostic performance of DWIMRI. MATERIALS AND METHODS: We analyzed 1.5T MRI examinations of 100 consecutive patients treated with radiation therapy with or without additional surgery for head and neck squamous cell carcinoma. MRI examinations included morphologic sequences and DWI (b=0 and b=1000 s/mm2). Histology and follow-up served as the standard of reference. Two experienced readers, blinded to clinical/histologic/follow-up data, evaluated images according to clearly defined criteria for the diagnosis of recurrent head and neck squamous cell carcinoma/second primary head and neck squamous cell carcinoma occurring after treatment, post-radiation therapy inflammatory edema, and late fibrosis. DWI analysis included qualitative (visual) and quantitative evaluation with an ADC threshold. RESULTS: Recurrent head and neck squamous cell carcinoma/second primary head and neck squamous cell carcinoma occurring after treatment was present in 36 patients, whereas 64 patients had post-radiation therapy lesions only. The Cohen κ for differentiating tumor from post-radiation therapy lesions with MRI and qualitative DWIMRI was 0.822 and 0.881, respectively. Mean ADCmean in recurrent head and neck squamous cell carcinoma/second primary head and neck squamous cell carcinoma occurring after treatment (1.097 ± 0.295 × 10−3 mm2/s) was significantly lower (P < .05) than in post-radiation therapy inflammatory edema (1.754 ± 0.343 × 10−3 mm2/s); however, it was similar to that in late fibrosis (0.987 ± 0.264 × 10−3 mm2/s, P > .05). Although ADCs were similar in tumors and late fibrosis, morphologic MRI criteria facilitated distinction between the 2 conditions. The sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios (95% CI) of DWIMRI with ADCmean < 1.22 × 10−3 mm2/s and precise MRI criteria were 92.1% (83.5–100.0), 95.4% (90.3–100.0), 92.1% (83.5–100.0), 95.4% (90.2–100.0), 19.9 (6.58–60.5), and 0.08 (0.03–0.24), respectively, indicating a good diagnostic performance to rule in and rule out disease. CONCLUSIONS: Adding precise morphologic MRI criteria to quantitative DWI enables reproducible and accurate detection of recurrent head and neck squamous cell carcinoma/second primary head and neck squamous cell carcinoma occurring after treatment.


31 July 2021
Verified
Conference Paper
Open access
PMPravin Mundada
Pravin Mundada
The petrygopalatine fossa (PPF) is a crucial neurovascular junction in the deep face with important communications to other deep spaces & to the intracranial compartment. Being aware of its anatomy, communications & key imaging findings in pathology helps to accurately detect disease especially perineural tumour spread (PNS). The PPF should always be a key review area in both pre &